LV15558A - Selenofēnhromēnfosfonskābes, to iegūšana un izmantošana par pretaudzēju aģentiem - Google Patents

Selenofēnhromēnfosfonskābes, to iegūšana un izmantošana par pretaudzēju aģentiem

Info

Publication number
LV15558A
LV15558A LVP-19-46A LV190046A LV15558A LV 15558 A LV15558 A LV 15558A LV 190046 A LV190046 A LV 190046A LV 15558 A LV15558 A LV 15558A
Authority
LV
Latvia
Prior art keywords
selenophenochromene
phosphonic acids
antiproliferative agents
preparation
disorders
Prior art date
Application number
LVP-19-46A
Other languages
English (en)
Inventor
Pavels Arsenjans
Ilona Domračeva
Edgars PAEGLE
Original Assignee
Latvijas Organiskās Sintēzes Institūts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Latvijas Organiskās Sintēzes Institūts filed Critical Latvijas Organiskās Sintēzes Institūts
Priority to LVP-19-46A priority Critical patent/LV15558A/lv
Priority to PCT/IB2020/052685 priority patent/WO2021038306A1/en
Publication of LV15558A publication Critical patent/LV15558A/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Šis izgudrojums ir saistīts ar jaunām selēnofēnhromēnfosfonskābēm kā pretaudzēju aģentiem, kā arī šo savienojumu sintēzes metodēm un šo savienojumu izmantošanu dažādos farmaceitiskajos sastāvos, lai ārstētu vai novērstu dažādas slimības, administrējot šādas vielas.
LVP-19-46A 2019-08-28 2019-08-28 Selenofēnhromēnfosfonskābes, to iegūšana un izmantošana par pretaudzēju aģentiem LV15558A (lv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LVP-19-46A LV15558A (lv) 2019-08-28 2019-08-28 Selenofēnhromēnfosfonskābes, to iegūšana un izmantošana par pretaudzēju aģentiem
PCT/IB2020/052685 WO2021038306A1 (en) 2019-08-28 2020-03-23 Selenophenochromene phosphonic acids, preparation and use as antiproliferative agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-19-46A LV15558A (lv) 2019-08-28 2019-08-28 Selenofēnhromēnfosfonskābes, to iegūšana un izmantošana par pretaudzēju aģentiem

Publications (1)

Publication Number Publication Date
LV15558A true LV15558A (lv) 2021-03-20

Family

ID=68382473

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-19-46A LV15558A (lv) 2019-08-28 2019-08-28 Selenofēnhromēnfosfonskābes, to iegūšana un izmantošana par pretaudzēju aģentiem

Country Status (2)

Country Link
LV (1) LV15558A (lv)
WO (1) WO2021038306A1 (lv)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018073219B1 (pt) 2016-07-21 2020-06-16 Latvian Institute Of Organic Synthesis Composto de fórmula i, composição farmacêutica, processo para síntese destes compostos e uso dos mesmos

Also Published As

Publication number Publication date
WO2021038306A1 (en) 2021-03-04

Similar Documents

Publication Publication Date Title
MX2021004431A (es) Procesos novedosos.
WO2017053868A8 (en) C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses
WO2018060732A3 (en) Compositions and methods for treating seizure disorders
WO2019032662A8 (en) Clec9a binding agents and use thereof
WO2017194782A3 (en) Therapeutic targeting of non-cellular structures
MX2016010213A (es) Formulaciones farmaceuticas novedosas.
MX2021015936A (es) Metodos para preparar acido bempedoico y composiciones del mismo.
PH12020550341A1 (en) Niraparib formulations
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
EA201992607A1 (ru) Твердые формы берберина урсодезоксихолата, их композиции и способы
WO2018111315A8 (en) PYRIMIDINE TRICYCLIC ENONE DERIVATIVES FOR INHIBITION OF RORγ AND OTHER USES
PH12021550872A1 (en) Therapeutic compounds
SG10201907289VA (en) Monomethylfumarate prodrug compositions
MX2021011596A (es) Compuestos y composiciones como moduladores de se?alizacion tlr.
MX2022000712A (es) Moduladores de nlrp3.
MX2021004860A (es) Piridazinas novedosas.
PH12019502510A1 (en) Pharmaceutical composition and pharmaceutical dosage form comprising (e)-4-(2-(aminomethyl)-3-fluoroallyloxy)-n-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof
WO2015048188A8 (en) Modified fibroblast growth factors for the treatment of ocular disorders
MX2023003348A (es) Compuestos y composiciones como moduladores de señalización tlr.
MX2020001256A (es) Compuestos para la prevencion y el tratamiento de trastornos medicos y usos de los mismos.
MX2022004382A (es) Metodos para promover la produccion de scfa por microbiota intestinal.
JP2019529569A5 (lv)
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
LV15558A (lv) Selenofēnhromēnfosfonskābes, to iegūšana un izmantošana par pretaudzēju aģentiem
MX2019009909A (es) Composiciones farmaceuticas para terapia de combinacion.